Clinical trial
Phase I/II Study of Fractionated Stereotactic Radiotherapy for Medically…
NCT00351962 · AHS Cancer Control Alberta, Other · Completed
Key facts
| NCT number | NCT00351962 |
|---|---|
| Title | Phase I/II Study of Fractionated Stereotactic Radiotherapy for Medically Inoperable NSCLC or Metastatic Lung Tumours |
| Official title | Phase I/II Study of Fractionated Stereotactic Radiotherapy for Medically Inoperable Non-Small Cell Lung Cancer (NSCLC) or Metastatic Lung Tumours |
| Lead sponsor | AHS Cancer Control Alberta, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Lung Neoplasms, Lung Cancer |
| Intervention type | Procedure |
| Interventions | Fractionated Stereotactic Radiotherapy |
| Enrollment | 58 |
| Start date | Sep 1, 2006 |
| Primary completion | Jul 1, 2014 |
| Completion | Jul 2, 2014 |
| First posted | Jul 13, 2006 |
| Last update posted | Sep 21, 2017 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: